June 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated diabetes, according to data presented at the American Diabetes Association Scientific Sessions.In the AIDING randomized controlled trial, hospitalized adults with diabetes who used the Omnipod 5 (Insulet) automated insulin delivery system along with the Dexcom
June 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

Triple hormone receptors, a monthly obesity drug, and a bittersweet ending

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1

Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control

The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a…

NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and…

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…

Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to…

Children with type 1 diabetes had similar long-term glycemic outcomes with two different automated insulin delivery systems,…

NEW ORLEANS — In patients with gestational diabetes who took insulin after a standardized breakfast meal, inhaled technosphere…